Table of Content

1 Human Vaccine Market Overview
1.1 Human Vaccine Product Overview
1.2 Human Vaccine Market Segment by Type
1.2.1 Varicella
1.2.2 Influenza
1.2.3 Polio
1.2.4 Hepatitis A
1.2.5 Rabies
1.2.6 BCG
1.2.7 Hepatitis B
1.2.8 Pertussis, Diphtheria, Tetanus
1.2.9 Pneumococcal
1.2.10 Rota vaccine
1.3 Global Human Vaccine Market Size by Type
1.3.1 Global Human Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global Human Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Human Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Human Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Human Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Human Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Human Vaccine Sales Breakdown by Type (2018-2024)
2 Global Human Vaccine Market Competition by Company
2.1 Global Top Players by Human Vaccine Sales (2018-2024)
2.2 Global Top Players by Human Vaccine Revenue (2018-2024)
2.3 Global Top Players by Human Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Human Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Vaccine Market Competitive Situation and Trends
2.5.1 Human Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Human Vaccine Market
2.8 Key Manufacturers Human Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Vaccine Status and Outlook by Region
3.1 Global Human Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Human Vaccine Historic Market Size by Region
3.2.1 Global Human Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Human Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Human Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Human Vaccine Forecasted Market Size by Region
3.3.1 Global Human Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Human Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Human Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Human Vaccine by Application
4.1 Human Vaccine Market Segment by Application
4.1.1 Adults
4.1.2 Children
4.2 Global Human Vaccine Market Size by Application
4.2.1 Global Human Vaccine Market Size Overview by Application (2018-2034)
4.2.2 Global Human Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Human Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Human Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Human Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Human Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Human Vaccine Sales Breakdown by Application (2018-2024)
5 North America Human Vaccine by Country
5.1 North America Human Vaccine Historic Market Size by Country
5.1.1 North America Human Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Human Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Human Vaccine Sales in Value by Country (2018-2024)
5.2 North America Human Vaccine Forecasted Market Size by Country
5.2.1 North America Human Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Human Vaccine Sales in Value by Country (2024-2034)
6 Europe Human Vaccine by Country
6.1 Europe Human Vaccine Historic Market Size by Country
6.1.1 Europe Human Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Human Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Human Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Human Vaccine Forecasted Market Size by Country
6.2.1 Europe Human Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Human Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Human Vaccine by Region
7.1 Asia-Pacific Human Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Human Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Human Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Human Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Human Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Human Vaccine Sales in Value by Region (2024-2034)
8 Latin America Human Vaccine by Country
8.1 Latin America Human Vaccine Historic Market Size by Country
8.1.1 Latin America Human Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Human Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Human Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Human Vaccine Forecasted Market Size by Country
8.2.1 Latin America Human Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Human Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Human Vaccine by Country
9.1 Middle East and Africa Human Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Human Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Human Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Human Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Human Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Human Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 CNBG
10.1.1 CNBG Company Information
10.1.2 CNBG Introduction and Business Overview
10.1.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 CNBG Human Vaccine Products Offered
10.1.5 CNBG Recent Development
10.2 Changsheng Life
10.2.1 Changsheng Life Company Information
10.2.2 Changsheng Life Introduction and Business Overview
10.2.3 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Changsheng Life Human Vaccine Products Offered
10.2.5 Changsheng Life Recent Development
10.3 Zhifei
10.3.1 Zhifei Company Information
10.3.2 Zhifei Introduction and Business Overview
10.3.3 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Zhifei Human Vaccine Products Offered
10.3.5 Zhifei Recent Development
10.4 ChengDa Bio
10.4.1 ChengDa Bio Company Information
10.4.2 ChengDa Bio Introduction and Business Overview
10.4.3 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 ChengDa Bio Human Vaccine Products Offered
10.4.5 ChengDa Bio Recent Development
10.5 Kangtai
10.5.1 Kangtai Company Information
10.5.2 Kangtai Introduction and Business Overview
10.5.3 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Kangtai Human Vaccine Products Offered
10.5.5 Kangtai Recent Development
10.6 SINOVAC BIOTECH
10.6.1 SINOVAC BIOTECH Company Information
10.6.2 SINOVAC BIOTECH Introduction and Business Overview
10.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 SINOVAC BIOTECH Human Vaccine Products Offered
10.6.5 SINOVAC BIOTECH Recent Development
10.7 Hissen
10.7.1 Hissen Company Information
10.7.2 Hissen Introduction and Business Overview
10.7.3 Hissen Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Hissen Human Vaccine Products Offered
10.7.5 Hissen Recent Development
10.8 Walvax Biotechnology
10.8.1 Walvax Biotechnology Company Information
10.8.2 Walvax Biotechnology Introduction and Business Overview
10.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Walvax Biotechnology Human Vaccine Products Offered
10.8.5 Walvax Biotechnology Recent Development
10.9 GSK
10.9.1 GSK Company Information
10.9.2 GSK Introduction and Business Overview
10.9.3 GSK Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 GSK Human Vaccine Products Offered
10.9.5 GSK Recent Development
10.10 SANOFI
10.10.1 SANOFI Company Information
10.10.2 SANOFI Introduction and Business Overview
10.10.3 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 SANOFI Human Vaccine Products Offered
10.10.5 SANOFI Recent Development
10.11 Rong An
10.11.1 Rong An Company Information
10.11.2 Rong An Introduction and Business Overview
10.11.3 Rong An Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Rong An Human Vaccine Products Offered
10.11.5 Rong An Recent Development
10.12 NuoCheng Bio
10.12.1 NuoCheng Bio Company Information
10.12.2 NuoCheng Bio Introduction and Business Overview
10.12.3 NuoCheng Bio Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.12.4 NuoCheng Bio Human Vaccine Products Offered
10.12.5 NuoCheng Bio Recent Development
10.13 Hualan Bio
10.13.1 Hualan Bio Company Information
10.13.2 Hualan Bio Introduction and Business Overview
10.13.3 Hualan Bio Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Hualan Bio Human Vaccine Products Offered
10.13.5 Hualan Bio Recent Development
10.14 Tiantan biological
10.14.1 Tiantan biological Company Information
10.14.2 Tiantan biological Introduction and Business Overview
10.14.3 Tiantan biological Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Tiantan biological Human Vaccine Products Offered
10.14.5 Tiantan biological Recent Development
10.15 Changchun Baike
10.15.1 Changchun Baike Company Information
10.15.2 Changchun Baike Introduction and Business Overview
10.15.3 Changchun Baike Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Changchun Baike Human Vaccine Products Offered
10.15.5 Changchun Baike Recent Development
10.16 Adimmune
10.16.1 Adimmune Company Information
10.16.2 Adimmune Introduction and Business Overview
10.16.3 Adimmune Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Adimmune Human Vaccine Products Offered
10.16.5 Adimmune Recent Development
10.17 Zhongyianke Biotech
10.17.1 Zhongyianke Biotech Company Information
10.17.2 Zhongyianke Biotech Introduction and Business Overview
10.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Zhongyianke Biotech Human Vaccine Products Offered
10.17.5 Zhongyianke Biotech Recent Development
10.18 Bharat Biotech
10.18.1 Bharat Biotech Company Information
10.18.2 Bharat Biotech Introduction and Business Overview
10.18.3 Bharat Biotech Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Bharat Biotech Human Vaccine Products Offered
10.18.5 Bharat Biotech Recent Development
10.19 Bavarian Nordic
10.19.1 Bavarian Nordic Company Information
10.19.2 Bavarian Nordic Introduction and Business Overview
10.19.3 Bavarian Nordic Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Bavarian Nordic Human Vaccine Products Offered
10.19.5 Bavarian Nordic Recent Development
10.20 Sanofi-Pasteur
10.20.1 Sanofi-Pasteur Company Information
10.20.2 Sanofi-Pasteur Introduction and Business Overview
10.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Sanofi-Pasteur Human Vaccine Products Offered
10.20.5 Sanofi-Pasteur Recent Development
10.21 Indian Immunologicals
10.21.1 Indian Immunologicals Company Information
10.21.2 Indian Immunologicals Introduction and Business Overview
10.21.3 Indian Immunologicals Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Indian Immunologicals Human Vaccine Products Offered
10.21.5 Indian Immunologicals Recent Development
10.22 KANGH
10.22.1 KANGH Company Information
10.22.2 KANGH Introduction and Business Overview
10.22.3 KANGH Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.22.4 KANGH Human Vaccine Products Offered
10.22.5 KANGH Recent Development
10.23 Henan Grand Biopharma
10.23.1 Henan Grand Biopharma Company Information
10.23.2 Henan Grand Biopharma Introduction and Business Overview
10.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.23.4 Henan Grand Biopharma Human Vaccine Products Offered
10.23.5 Henan Grand Biopharma Recent Development
10.24 ZhongKe Biopharm
10.24.1 ZhongKe Biopharm Company Information
10.24.2 ZhongKe Biopharm Introduction and Business Overview
10.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.24.4 ZhongKe Biopharm Human Vaccine Products Offered
10.24.5 ZhongKe Biopharm Recent Development
10.25 Zhuoyi Biological
10.25.1 Zhuoyi Biological Company Information
10.25.2 Zhuoyi Biological Introduction and Business Overview
10.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.25.4 Zhuoyi Biological Human Vaccine Products Offered
10.25.5 Zhuoyi Biological Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Vaccine Industrial Chain Analysis
11.4 Human Vaccine Market Dynamics
11.4.1 Human Vaccine Industry Trends
11.4.2 Human Vaccine Market Drivers
11.4.3 Human Vaccine Market Challenges
11.4.4 Human Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Vaccine Distributors
12.3 Human Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Varicella
Table 2. Major Company of Influenza
Table 3. Major Company of Polio
Table 4. Major Company of Hepatitis A
Table 5. Major Company of Rabies
Table 6. Major Company of BCG
Table 7. Major Company of Hepatitis B
Table 8. Major Company of Pertussis, Diphtheria, Tetanus
Table 9. Major Company of Pneumococcal
Table 10. Major Company of Rota vaccine
Table 11. Global Human Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 12. Global Human Vaccine Sales by Type (2018-2024) & (M Doses)
Table 13. Global Human Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 14. Global Human Vaccine Sales by Type (2018-2024) & (US& Million)
Table 15. Global Human Vaccine Market Share in Value by Type (2018-2024)
Table 16. Global Human Vaccine Price by Type (2018-2024) & (USD/Dose)
Table 17. Global Human Vaccine Sales by Type (2024-2034) & (M Doses)
Table 18. Global Human Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 19. Global Human Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 20. Global Human Vaccine Sales Market Share in Value by Type (2024-2034)
Table 21. Global Human Vaccine Price by Type (2024-2034) & (USD/Dose)
Table 22. North America Human Vaccine Sales by Type (2018-2024) & (M Doses)
Table 23. North America Human Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Europe Human Vaccine Sales (M Doses) by Type (2018-2024)
Table 25. Europe Human Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 26. Asia-Pacific Human Vaccine Sales (M Doses) by Type (2018-2024)
Table 27. Asia-Pacific Human Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 28. Latin America Human Vaccine Sales (M Doses) by Type (2018-2024)
Table 29. Latin America Human Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 30. Middle East and Africa Human Vaccine Sales (M Doses) by Type (2018-2024)
Table 31. Middle East and Africa Human Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 32. Global Human Vaccine Sales by Company (2018-2024) & (M Doses)
Table 33. Global Human Vaccine Sales Share by Company (2018-2024)
Table 34. Global Human Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 35. Global Human Vaccine Revenue Share by Company (2018-2024)
Table 36. Global Market Human Vaccine Price by Company (2018-2024) & (USD/Dose)
Table 37. Global Human Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 38. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 39. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Vaccine as of 2022)
Table 40. Date of Key Manufacturers Enter into Human Vaccine Market
Table 41. Key Manufacturers Human Vaccine Product Type
Table 42. Mergers & Acquisitions, Expansion Plans
Table 43. Global Human Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 44. Global Human Vaccine Sales by Region (2018-2024) & (M Doses)
Table 45. Global Human Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 46. Global Human Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 47. Global Human Vaccine Sales Market Share in Value by Region (2018-2024)
Table 48. Global Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 49. Global Human Vaccine Sales by Region (2024-2034) & (M Doses)
Table 50. Global Human Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 51. Global Human Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 52. Global Human Vaccine Sales Market Share in Value by Region (2024-2034)
Table 53. Global Human Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2034)
Table 54. Global Human Vaccine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 55. Global Human Vaccine Sales by Application (2018-2024) & (M Doses)
Table 56. Global Human Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 57. Global Human Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 58. Global Human Vaccine Sales Market Share in Value by Application (2018-2024)
Table 59. Global Human Vaccine Price by Application (2018-2024) & (USD/Dose)
Table 60. Global Human Vaccine Sales by Application (2024-2034) & (M Doses)
Table 61. Global Human Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 62. Global Human Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 63. Global Human Vaccine Sales Market Share in Value by Application (2024-2034)
Table 64. Global Human Vaccine Price by Application (2024-2034) & (USD/Dose)
Table 65. North America Human Vaccine Sales by Application (2018-2024) (M Doses)
Table 66. North America Human Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. Europe Human Vaccine Sales by Application (2018-2024) (M Doses)
Table 68. Europe Human Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 69. Asia-Pacific Human Vaccine Sales by Application (2018-2024) (M Doses)
Table 70. Asia-Pacific Human Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 71. Latin America Human Vaccine Sales by Application (2018-2024) (M Doses)
Table 72. Latin America Human Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 73. Middle East and Africa Human Vaccine Sales by Application (2018-2024) (M Doses)
Table 74. Middle East and Africa Human Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 75. North America Human Vaccine Sales by Country (2018-2024) & (M Doses)
Table 76. North America Human Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. North America Human Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. North America Human Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. North America Human Vaccine Sales by Country (2024-2034) & (M Doses)
Table 80. North America Human Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 81. North America Human Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 82. North America Human Vaccine Sales Market Share in Value by Country (2024-2034)
Table 83. Europe Human Vaccine Sales by Country (2018-2024) & (M Doses)
Table 84. Europe Human Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 85. Europe Human Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 86. Europe Human Vaccine Sales Market Share in Value by Country (2018-2024)
Table 87. Europe Human Vaccine Sales by Country (2024-2034) & (M Doses)
Table 88. Europe Human Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 89. Europe Human Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 90. Europe Human Vaccine Sales Market Share in Value by Country (2024-2034)
Table 91. Asia-Pacific Human Vaccine Sales by Region (2018-2024) & (M Doses)
Table 92. Asia-Pacific Human Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 93. Asia-Pacific Human Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 94. Asia-Pacific Human Vaccine Sales Market Share in Value by Region (2018-2024)
Table 95. Asia-Pacific Human Vaccine Sales by Region (2024-2034) & (M Doses)
Table 96. Asia-Pacific Human Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 97. Asia-Pacific Human Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 98. Asia-Pacific Human Vaccine Sales Market Share in Value by Region (2024-2034)
Table 99. Latin America Human Vaccine Sales by Country (2018-2024) & (M Doses)
Table 100. Latin America Human Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Latin America Human Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Latin America Human Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Latin America Human Vaccine Sales by Country (2024-2034) & (M Doses)
Table 104. Latin America Human Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 105. Latin America Human Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 106. Latin America Human Vaccine Sales Market Share in Value by Country (2024-2034)
Table 107. Middle East and Africa Human Vaccine Sales by Country (2018-2024) & (M Doses)
Table 108. Middle East and Africa Human Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 109. Middle East and Africa Human Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 110. Middle East and Africa Human Vaccine Sales Market Share in Value by Country (2018-2024)
Table 111. Middle East and Africa Human Vaccine Sales by Country (2024-2034) & (M Doses)
Table 112. Middle East and Africa Human Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 113. Middle East and Africa Human Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 114. Middle East and Africa Human Vaccine Sales Market Share in Value by Country (2024-2034)
Table 115. CNBG Company Information
Table 116. CNBG Introduction and Business Overview
Table 117. CNBG Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 118. CNBG Human Vaccine Product
Table 119. CNBG Recent Development
Table 120. Changsheng Life Company Information
Table 121. Changsheng Life Introduction and Business Overview
Table 122. Changsheng Life Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 123. Changsheng Life Human Vaccine Product
Table 124. Changsheng Life Recent Development
Table 125. Zhifei Company Information
Table 126. Zhifei Introduction and Business Overview
Table 127. Zhifei Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 128. Zhifei Human Vaccine Product
Table 129. Zhifei Recent Development
Table 130. ChengDa Bio Company Information
Table 131. ChengDa Bio Introduction and Business Overview
Table 132. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 133. ChengDa Bio Human Vaccine Product
Table 134. ChengDa Bio Recent Development
Table 135. Kangtai Company Information
Table 136. Kangtai Introduction and Business Overview
Table 137. Kangtai Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 138. Kangtai Human Vaccine Product
Table 139. Kangtai Recent Development
Table 140. SINOVAC BIOTECH Company Information
Table 141. SINOVAC BIOTECH Introduction and Business Overview
Table 142. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 143. SINOVAC BIOTECH Human Vaccine Product
Table 144. SINOVAC BIOTECH Recent Development
Table 145. Hissen Company Information
Table 146. Hissen Introduction and Business Overview
Table 147. Hissen Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 148. Hissen Human Vaccine Product
Table 149. Hissen Recent Development
Table 150. Walvax Biotechnology Company Information
Table 151. Walvax Biotechnology Introduction and Business Overview
Table 152. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 153. Walvax Biotechnology Human Vaccine Product
Table 154. Walvax Biotechnology Recent Development
Table 155. GSK Company Information
Table 156. GSK Introduction and Business Overview
Table 157. GSK Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 158. GSK Human Vaccine Product
Table 159. GSK Recent Development
Table 160. SANOFI Company Information
Table 161. SANOFI Introduction and Business Overview
Table 162. SANOFI Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 163. SANOFI Human Vaccine Product
Table 164. SANOFI Recent Development
Table 165. Rong An Company Information
Table 166. Rong An Introduction and Business Overview
Table 167. Rong An Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 168. Rong An Human Vaccine Product
Table 169. Rong An Recent Development
Table 170. NuoCheng Bio Company Information
Table 171. NuoCheng Bio Introduction and Business Overview
Table 172. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 173. NuoCheng Bio Human Vaccine Product
Table 174. NuoCheng Bio Recent Development
Table 175. Hualan Bio Company Information
Table 176. Hualan Bio Introduction and Business Overview
Table 177. Hualan Bio Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 178. Hualan Bio Human Vaccine Product
Table 179. Hualan Bio Recent Development
Table 180. Tiantan biological Company Information
Table 181. Tiantan biological Introduction and Business Overview
Table 182. Tiantan biological Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 183. Tiantan biological Human Vaccine Product
Table 184. Tiantan biological Recent Development
Table 185. Changchun Baike Company Information
Table 186. Changchun Baike Introduction and Business Overview
Table 187. Changchun Baike Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 188. Changchun Baike Human Vaccine Product
Table 189. Changchun Baike Recent Development
Table 190. Adimmune Company Information
Table 191. Adimmune Introduction and Business Overview
Table 192. Adimmune Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 193. Adimmune Human Vaccine Product
Table 194. Adimmune Recent Development
Table 195. Zhongyianke Biotech Company Information
Table 196. Zhongyianke Biotech Introduction and Business Overview
Table 197. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 198. Zhongyianke Biotech Human Vaccine Product
Table 199. Zhongyianke Biotech Recent Development
Table 200. Bharat Biotech Company Information
Table 201. Bharat Biotech Introduction and Business Overview
Table 202. Bharat Biotech Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 203. Bharat Biotech Human Vaccine Product
Table 204. Bharat Biotech Recent Development
Table 205. Bavarian Nordic Company Information
Table 206. Bavarian Nordic Introduction and Business Overview
Table 207. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 208. Bavarian Nordic Human Vaccine Product
Table 209. Bavarian Nordic Recent Development
Table 210. Sanofi-Pasteur Company Information
Table 211. Sanofi-Pasteur Introduction and Business Overview
Table 212. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 213. Sanofi-Pasteur Human Vaccine Product
Table 214. Sanofi-Pasteur Recent Development
Table 215. Indian Immunologicals Company Information
Table 216. Indian Immunologicals Introduction and Business Overview
Table 217. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 218. Indian Immunologicals Human Vaccine Product
Table 219. Indian Immunologicals Recent Development
Table 220. KANGH Company Information
Table 221. KANGH Introduction and Business Overview
Table 222. KANGH Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 223. KANGH Human Vaccine Product
Table 224. KANGH Recent Development
Table 225. Henan Grand Biopharma Company Information
Table 226. Henan Grand Biopharma Introduction and Business Overview
Table 227. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 228. Henan Grand Biopharma Human Vaccine Product
Table 229. Henan Grand Biopharma Recent Development
Table 230. ZhongKe Biopharm Company Information
Table 231. ZhongKe Biopharm Introduction and Business Overview
Table 232. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 233. ZhongKe Biopharm Human Vaccine Product
Table 234. ZhongKe Biopharm Recent Development
Table 235. Zhuoyi Biological Introduction and Business Overview
Table 236. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 237. Zhuoyi Biological Human Vaccine Product
Table 238. Zhuoyi Biological Recent Development
Table 239. Zhuoyi Biological Company Information
Table 240. Key Raw Materials Lists
Table 241. Raw Materials Key Suppliers Lists
Table 242. Human Vaccine Market Trends
Table 243. Human Vaccine Market Drivers
Table 244. Human Vaccine Market Challenges
Table 245. Human Vaccine Market Restraints
Table 246. Human Vaccine Distributors List
Table 247. Human Vaccine Downstream Customers
Table 248. Research Programs/Design for This Report
Table 249. Key Data Information from Secondary Sources
Table 250. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Vaccine Product Picture
Figure 2. Global Human Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Human Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Human Vaccine Sales Status and Outlook (2018-2034) & (M Doses)
Figure 5. Product Picture of Varicella
Figure 6. Global Varicella Sales YoY Growth (2018-2034) & (M Doses)
Figure 7. Product Picture of Influenza
Figure 8. Global Influenza Sales YoY Growth (2018-2034) & (M Doses)
Figure 9. Product Picture of Polio
Figure 10. Global Polio Sales YoY Growth (2018-2034) & (M Doses)
Figure 11. Product Picture of Hepatitis A
Figure 12. Global Hepatitis A Sales YoY Growth (2018-2034) & (M Doses)
Figure 13. Product Picture of Rabies
Figure 14. Global Rabies Sales YoY Growth (2018-2034) & (M Doses)
Figure 15. Product Picture of BCG
Figure 16. Global BCG Sales YoY Growth (2018-2034) & (M Doses)
Figure 17. Product Picture of Hepatitis B
Figure 18. Global Hepatitis B Sales YoY Growth (2018-2034) & (M Doses)
Figure 19. Product Picture of Pertussis, Diphtheria, Tetanus
Figure 20. Global Pertussis, Diphtheria, Tetanus Sales YoY Growth (2018-2034) & (M Doses)
Figure 21. Product Picture of Pneumococcal
Figure 22. Global Pneumococcal Sales YoY Growth (2018-2034) & (M Doses)
Figure 23. Product Picture of Rota vaccine
Figure 24. Global Rota vaccine Sales YoY Growth (2018-2034) & (M Doses)
Figure 25. Global Human Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 26. Global Human Vaccine Sales Market Share by Type in 2022 & 2034
Figure 27. North America Human Vaccine Sales Market Share in Volume by Type in 2022
Figure 28. North America Human Vaccine Sales Market Share in Value by Type in 2022
Figure 29. Europe Human Vaccine Sales Market Share in Volume by Type in 2022
Figure 30. Europe Human Vaccine Sales Market Share in Value by Type in 2022
Figure 31. Asia-Pacific Human Vaccine Sales Market Share in Volume by Type in 2022
Figure 32. Asia-Pacific Human Vaccine Sales Market Share in Value by Type in 2022
Figure 33. Latin America Human Vaccine Sales Market Share in Volume by Type in 2022
Figure 34. Latin America Human Vaccine Sales Market Share in Value by Type in 2022
Figure 35. Middle East and Africa Human Vaccine Sales Market Share in Volume by Type in 2022
Figure 36. Middle East and Africa Human Vaccine Sales Market Share in Value by Type in 2022
Figure 37. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Vaccine Sales in 2022
Figure 38. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Vaccine Revenue in 2022
Figure 39. Human Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 40. Product Picture of Adults
Figure 41. Global Adults Sales YoY Growth (2018-2034) & (M Doses)
Figure 42. Product Picture of Children
Figure 43. Global Children Sales YoY Growth (2018-2034) & (M Doses)
Figure 44. Global Human Vaccine Sales by Application (2018-2034) & (US$ Million)
Figure 45. Global Human Vaccine Sales Market Share by Application in 2022 & 2034
Figure 46. North America Human Vaccine Sales Market Share in Volume by Application in 2022
Figure 47. North America Human Vaccine Sales Market Share in Value by Application in 2022
Figure 48. Europe Human Vaccine Sales Market Share in Volume by Application in 2022
Figure 49. Europe Human Vaccine Sales Market Share in Value by Application in 2022
Figure 50. Asia-Pacific Human Vaccine Sales Market Share in Volume by Application in 2022
Figure 51. Asia-Pacific Human Vaccine Sales Market Share in Value by Application in 2022
Figure 52. Latin America Human Vaccine Sales Market Share in Volume by Application in 2022
Figure 53. Latin America Human Vaccine Sales Market Share in Value by Application in 2022
Figure 54. Middle East and Africa Human Vaccine Sales Market Share in Value by Application in 2022
Figure 55. Key Raw Materials Price
Figure 56. Human Vaccine Manufacturing Cost Structure
Figure 57. Human Vaccine Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed